Stifel Initiates Coverage On Immunome with Hold Rating, Announces Price Target of $24

Benzinga Newsdesk www.benzinga.com Positive 53.0%

Neg 0% Neu 0% Pos 53%

Stifel analyst Dara Azar initiates coverage on Immunome (NASDAQ:IMNM) with a Hold rating and announces Price Target of $24.